Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
spl-108 | extracellular matrix receptor iii | NA | Clinical trial target | TTD | Epithelial ovarian cancer[MeSHID:C538090] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] |
NA | phase 2 | unknown |
click here to return to the previous page |